For high-cost, narrow margin procedures such as TAVR, deliberate integration of clinical, operational, and financial analytics is essential to support value-based care and long-term program viability. Clinical excellence alone is not sufficient; aligning quality outcomes with operational and financial analytics is critical to delivery truly value-based structural heart care.